GAM
CTSO icon

Gemmer Asset Management’s Cytosorbents Corp CTSO Stock Holding History

Gemmer Asset Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-400
Closed -$3K – 1298
2021
Q2 		$3K Hold
400
– – ﹤0.01% 1276
2021
Q1 		$3K Hold
400
– – ﹤0.01% 1249
2020
Q4 		$3K Buy
+400
New +$3.35K ﹤0.01% 1197

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gemmer Asset Management's CTSO Position: Q3 2021 in Review

Gemmer Asset Management sold out of Cytosorbents Corp (CTSO) in Q3 2021, closing a stake of 400 shares — an estimated $3K sold.

Gemmer Asset Management first reported a position in CTSO in Q4 2020 and held it in 3 quarters. The position peaked at $3K in Q2 2021. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2021.

  • Gemmer Asset Management reported no remaining Cytosorbents Corp position as of Q3 2021 after selling out during the quarter.
  • Gemmer Asset Management sold 400 Cytosorbents Corp shares in Q3 2021, an estimated $3K.
  • Gemmer Asset Management first reported a position in Cytosorbents Corp in Q4 2020 and held it in 3 quarters.
  • Gemmer Asset Management's Cytosorbents Corp position peaked at $3K in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2021.

Based on Gemmer Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.